A Novel Alternative to Classify Tissues from T 1 and T 2 Relaxation Times for Prostate MRI

Overview

Journal MAGMA

Publisher Springer

Date 2016 May 11

PMID 27160300

Citations 11

Authors

Jorge Zavala Bojorquez

Stephanie Bricq

Francois Brunotte

Paul M Walker

Alain Lalande

Affiliations

Soon will be listed here.

Abstract

Objective: To segment and classify the different attenuation regions from MRI at the pelvis level using the T 1 and T 2 relaxation times and anatomical knowledge as a first step towards the creation of PET/MR attenuation maps.

Materials And Methods: Relaxation times were calculated by fitting the pixel-wise intensities of acquired T 1- and T 2-weighted images from eight men with inversion-recovery and multi-echo multi-slice spin-echo sequences. A decision binary tree based on relaxation times was implemented to segment and classify fat, muscle, prostate, and air (within the body). Connected component analysis and an anatomical knowledge-based procedure were implemented to localize the background and bone.

Results: Relaxation times at 3 T are reported for fat (T 1 = 385 ms, T 2 = 121 ms), muscle (T 1 = 1295 ms, T 2 = 40 ms), and prostate (T 1 = 1700 ms, T 2 = 80 ms). The relaxation times allowed the segmentation-classification of fat, prostate, muscle, and air, and combined with anatomical knowledge, they allowed classification of bone. The good segmentation-classification of prostate [mean Dice similarity score (mDSC) = 0.70] suggests a viable implementation in oncology and that of fat (mDSC = 0.99), muscle (mDSC = 0.99), and bone (mDSCs = 0.78) advocates for its implementation in PET/MR attenuation correction.

Conclusion: Our method allows the segmentation and classification of the attenuation-relevant structures required for the generation of the attenuation map of PET/MR systems in prostate imaging: air, background, bone, fat, muscle, and prostate.

Citing Articles

The value of synthetic magnetic resonance imaging in the diagnosis and assessment of prostate cancer aggressiveness.

Gao Z, Xu X, Sun H, Li T, Ding W, Duan Y Quant Imaging Med Surg. 2024; 14(8):5473-5489.

PMID: 39143997 PMC: 11320532. DOI: 10.21037/qims-24-291.

A review of PET attenuation correction methods for PET-MR.

Krokos G, MacKewn J, Dunn J, Marsden P EJNMMI Phys. 2023; 10(1):52.

PMID: 37695384 PMC: 10495310. DOI: 10.1186/s40658-023-00569-0.

The Preoperative Diagnostic Performance of Multi-Parametric Quantitative Assessment in Rectal Carcinoma: A Preliminary Study Using Synthetic Magnetic Resonance Imaging.

Zhu K, Chen Z, Cui L, Zhao J, Liu Y, Cao J Front Oncol. 2022; 12:682003.

PMID: 35707367 PMC: 9190242. DOI: 10.3389/fonc.2022.682003.

Synthetic MRI for Radiotherapy Planning for Brain and Prostate Cancers: Phantom Validation and Patient Evaluation.

Gouel P, Hapdey S, Dumouchel A, Gardin I, Torfeh E, Hinault P Front Oncol. 2022; 12:841761.

PMID: 35515105 PMC: 9065558. DOI: 10.3389/fonc.2022.841761.

Pseudo-T2 mapping for normalization of T2-weighted prostate MRI.

Sorland K, Sunoqrot M, Sandsmark E, Langorgen S, Bertilsson H, Trimble C MAGMA. 2022; 35(4):573-585.

PMID: 35150363 PMC: 9363383. DOI: 10.1007/s10334-022-01003-9.

References

Zaidi H, Montandon M, Slosman D . Magnetic resonance imaging-guided attenuation and scatter corrections in three-dimensional brain positron emission tomography. Med Phys. 2003; 30(5):937-48. DOI: 10.1118/1.1569270. View

Bezrukov I, Mantlik F, Schmidt H, Scholkopf B, Pichler B . MR-Based PET attenuation correction for PET/MR imaging. Semin Nucl Med. 2012; 43(1):45-59. DOI: 10.1053/j.semnuclmed.2012.08.002. View

Sung K, Daniel B, Hargreaves B . Transmit B1+ field inhomogeneity and T1 estimation errors in breast DCE-MRI at 3 tesla. J Magn Reson Imaging. 2013; 38(2):454-9. PMC: 3620726. DOI: 10.1002/jmri.23996. View

Deoni S . High-resolution T1 mapping of the brain at 3T with driven equilibrium single pulse observation of T1 with high-speed incorporation of RF field inhomogeneities (DESPOT1-HIFI). J Magn Reson Imaging. 2007; 26(4):1106-11. DOI: 10.1002/jmri.21130. View

Edden R, Smith S, Barker P . Longitudinal and multi-echo transverse relaxation times of normal breast tissue at 3 Tesla. J Magn Reson Imaging. 2010; 32(4):982-7. PMC: 3154635. DOI: 10.1002/jmri.22306. View

Catana C, van der Kouwe A, Benner T, Michel C, Hamm M, Fenchel M . Toward implementing an MRI-based PET attenuation-correction method for neurologic studies on the MR-PET brain prototype. J Nucl Med. 2010; 51(9):1431-8. PMC: 3801218. DOI: 10.2967/jnumed.109.069112. View

Keereman V, Van Holen R, Mollet P, Vandenberghe S . The effect of errors in segmented attenuation maps on PET quantification. Med Phys. 2011; 38(11):6010-9. DOI: 10.1118/1.3651640. View

Keereman V, Fierens Y, Broux T, De Deene Y, Lonneux M, Vandenberghe S . MRI-based attenuation correction for PET/MRI using ultrashort echo time sequences. J Nucl Med. 2010; 51(5):812-8. DOI: 10.2967/jnumed.109.065425. View

Khateri P, Saligheh Rad H, Homayoun Jafari A, Kazerooni A, Akbarzadeh A, Shojae Moghadam M . Generation of a Four-Class Attenuation Map for MRI-Based Attenuation Correction of PET Data in the Head Area Using a Novel Combination of STE/Dixon-MRI and FCM Clustering. Mol Imaging Biol. 2015; 17(6):884-92. DOI: 10.1007/s11307-015-0849-1. View

10.

Kohan A, Paspulati R, Sherertz T, Mihaloew H, Herrmann K . Positron emission tomography-magnetic resonance imaging in oncologic diseases of the male and female pelvis. Semin Roentgenol. 2014; 49(4):334-44. DOI: 10.1053/j.ro.2014.04.002. View

11.

Barral J, Gudmundson E, Stikov N, Etezadi-Amoli M, Stoica P, Nishimura D . A robust methodology for in vivo T1 mapping. Magn Reson Med. 2010; 64(4):1057-67. PMC: 2962940. DOI: 10.1002/mrm.22497. View

12.

Gold G, Han E, Stainsby J, Wright G, Brittain J, Beaulieu C . Musculoskeletal MRI at 3.0 T: relaxation times and image contrast. AJR Am J Roentgenol. 2004; 183(2):343-51. DOI: 10.2214/ajr.183.2.1830343. View

13.

Liu W, Turkbey B, Senegas J, Remmele S, Xu S, Kruecker J . Accelerated T2 mapping for characterization of prostate cancer. Magn Reson Med. 2011; 65(5):1400-6. PMC: 3079019. DOI: 10.1002/mrm.22874. View

14.

Martinez-Moller A, Souvatzoglou M, Delso G, Bundschuh R, Chefdhotel C, Ziegler S . Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data. J Nucl Med. 2009; 50(4):520-6. DOI: 10.2967/jnumed.108.054726. View

15.

Johansson A, Karlsson M, Nyholm T . CT substitute derived from MRI sequences with ultrashort echo time. Med Phys. 2011; 38(5):2708-14. DOI: 10.1118/1.3578928. View

16.

Beyer T, Weigert M, Quick H, Pietrzyk U, Vogt F, Palm C . MR-based attenuation correction for torso-PET/MR imaging: pitfalls in mapping MR to CT data. Eur J Nucl Med Mol Imaging. 2008; 35(6):1142-6. DOI: 10.1007/s00259-008-0734-0. View

17.

Sung K, Saranathan M, Daniel B, Hargreaves B . Simultaneous T(1) and B(1) (+) mapping using reference region variable flip angle imaging. Magn Reson Med. 2013; 70(4):954-61. PMC: 3923865. DOI: 10.1002/mrm.24904. View

18.

Reichert I, Robson M, Gatehouse P, He T, Chappell K, Holmes J . Magnetic resonance imaging of cortical bone with ultrashort TE pulse sequences. Magn Reson Imaging. 2005; 23(5):611-8. DOI: 10.1016/j.mri.2005.02.017. View

19.

Gibbs P, Liney G, Pickles M, Zelhof B, Rodrigues G, Turnbull L . Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla. Invest Radiol. 2009; 44(9):572-6. DOI: 10.1097/RLI.0b013e3181b4c10e. View

20.

Fennessy F, Fedorov A, Gupta S, Schmidt E, Tempany C, Mulkern R . Practical considerations in T1 mapping of prostate for dynamic contrast enhancement pharmacokinetic analyses. Magn Reson Imaging. 2012; 30(9):1224-33. PMC: 3466364. DOI: 10.1016/j.mri.2012.06.011. View